Navigation Links
KaloBios Announces Fiscal Year 2012 Financial Results
Date:3/27/2013

nts and marketable securities totaling $20.3 million, compared to $17.8 million at December 31, 2011. On a pro-forma basis at December 31, 2012, including the net proceeds of our initial public offering completed in the first quarter of 2013, the cash, cash equivalent and marketable securities was approximately $83.8M. 

"KaloBios ended 2012 with a strong, differentiated clinical pipeline marked by three first-in-class, patient-targeted therapies for severe asthma, Pseudomonas infections associated with cystic fibrosis and pneumonia, and hematologic malignancies," said David Pritchard, KaloBios' President and Chief Executive Officer. "We continue to move forward aggressively to complete enrollment in the ongoing Phase 2 KB003 asthma study, our Phase 2 KB001-A cystic fibrosis (CF) study and our Phase 1 KB004 hematologic malignancy study."

Anticipated Upcoming Milestones for 2013-20142Q 2013:

File for Orphan Drug Status in the USA and European Union for KB001-A in CF3Q 2013:

Full recruitment of the KB003 asthma study3Q 2013:

Initiation of the expansion phase of the KB004 study in AML with EphA3 diagnostic test4Q 2013:

Full recruitment of the KB001-A CF study 1Q 2014:

Initiation of Phase 2 KB004 study in at least one new indication 1Q 2014:

Top line KB003 Phase 2 asthma study results2Q 2014:

Top line KB001-A CF study results3Q/4Q 2014:

Initiation of Sanofi Phase 2b study for prevention of ventilator-associated pneumonia (VAP) 4Q 2014:

Completion of enrollment in at least one hematologic malignancy indication in the expansion phase of KB004 About KaloBiosKaloBios Pharmaceuticals, Inc. is developing a portfolio of proprietary, patient-targeted, first-in-class monoclonal antibodies (mAbs) designed to significantly improve the lives of seriously ill patients with difficult-to-treat diseases.

Currently, KaloBios has three drug development programs:

  • KB0
    '/>"/>

  • SOURCE KaloBios Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. CfPIE Announces Advisory Board to Support Continued Life Sciences Training Alignment with Industry Regulations
    2. SoundConnect Announces Audio Conferencing Capacity Upgrades
    3. BMI Surplus Announces Sale of Thermal Vacuum Space Simulation Chamber
    4. XBiotech Announces Incorporation Of Its Wholly Owned Subsidiary XBiotech Japan KK
    5. National Brain Tumor Society Announces Launch of Defeat GBM Research Collaborative
    6. Regenerative Medicine Company, Eqalix, Announces Grant from Nanotechnology Institute in Philadelphia, Pennsylvania
    7. Probiotics Are in More Than Just Yogurt: Probiotic Action Announces 5 New Items Containing the Healthy Bacteria
    8. Synedgen Announces Issuance of Patent to Optimize Animal Health
    9. Piramal Imaging Announces the Acceptance for Review of [18F] florbetaben by the FDA and EMA for the Visual Detection of beta-amyloid in Alzheimers Disease
    10. Probiotic Action Announces Probiotics Pending Listing on EU Foods
    11. Butamax Announces Immediate Appeal of Court Decisions on Claim Construction and Summary Judgment
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/4/2015)... (PRWEB) March 04, 2015 PRC ... in the San Francisco Bay Area, will exhibit and ... Israel Conference 2015 on March 25th and 26th ... to build relationships with Israeli life science companies seeking ... trials. The company’s services span all phases of human ...
    (Date:3/4/2015)... Jose, California (PRWEB) March 04, 2015 ... Reaction (PCR) represents one of the fastest growing technologies ... cell biologists in subcellular visualization is driving growth in ... need for deeper understanding of gene expressions will continue ... market. Expanding applications in fields ranging from pharma, biotech, ...
    (Date:3/3/2015)... -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be ... Miami, FL on March 10, 2015 at ... Chief Financial Officer, will provide a corporate overview. ... Halozyme,s corporate website at www.halozyme.com , and a recording ... To access the live webcast, please log on to Halozyme,s ...
    (Date:3/3/2015)... 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... and Chief Executive Officer of Neurocrine Biosciences, will be ... The live presentation takes place on ... presentation will be webcast and may be accessed on ... Listeners are encouraged to visit the website approximately ...
    Breaking Biology Technology:PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 2PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 3PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 4Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 2Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 4Halozyme Therapeutics To Present At The Barclays 2015 Global Healthcare Conference 2
    ... gained another $12 million in venture capital in an investment ... that clinicians and researchers can use to do genetic tests, ... animals or people. The company says it has received $21 ... government grants and loans. , ,The funding round was led ...
    ... secretary of the U.S. Department of Health and Human ... , ,Alfacell develops cancer theraputics and is moving closer ... Food and Drug Administration for its lead drug candidate. ... it has a local presence. , ,"I first became ...
    ... now knows about Hwang Woo-suk, the South Korean researcher ... was a confidence-shaking revelation for some who support human ... for those who do not. , ,If theres ... South Korea, it is the contrast with how stem ...
    Cached Biology Technology:Stem cell breakthrough by UW shows why federal research should be broadened 2Stem cell breakthrough by UW shows why federal research should be broadened 3
    (Date:2/25/2015)... Feb. 25, 2015  ABC Financial Services (ABC), ... the Health and Fitness Industry, today announced enhancements ... MYiCLUBonline.  The latest upgrade includes advances to the ... cardless check-in via Identity One fingerprint biometrics. The ... through interactive displays at the International Health, Racquet ...
    (Date:2/23/2015)... , Feb. 23, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... provisional patent 62114357 for DISTRIBUTED VOICE DIRECTED ... NXT-ID introduces a new groundbreaking payment method. Payment accounts ... account may only be accessed if both the speech ...
    (Date:2/12/2015)... Minn. , Feb. 12, 2015   ... company specializing in clinical study management systems, has ... Program , further distinguishing iMedNet ... Clinical Research Organizations (CROs) and healthcare consultants.  Building ... support, prospective customer referrals and numerous co-marketing opportunities), ...
    Breaking Biology News(10 mins):ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2
    ... When diners belly-up to a buffet, food order matters. When ... the higher calorie dishes later in the line, says a ... Oct 23. ,"Each food taken may partly determine what ... food a person selects triggers what they take next," write ...
    ... Initial results of a first and largest of its ... surgery were published this week in JAMA Pediatrics ... (Teen-LABS) study is funded by the National Institutes of ... in the U.S., including Nationwide Children,s Hospital. Thomas ...
    ... a key role in glucose regulation and the development of type ... journal Nature . If the hypothesis is correct, it may ... this disease, which is projected to affect one in three adults ... author Dr. Michael W. Schwartz, director of the Diabetes and Obesity ...
    Cached Biology News:Findings announced from landmark study on safety of adolescent bariatric surgery 2Brain may play key role in blood sugar metabolism and development of diabetes 2
    MOUSE ANTI PROTEIN KINASE C BETA 2 Immunogen: Protein kinase C beta 2...
    ... Captivate magnetic separator for six ... in conjunction with the Captivate ... or other magnetic particles and ... microcentrifuge tubes. Cell Biology Cell ...
    MOUSE ANTI POLY (ADP-RIBOSE) Immunogen: Purified poly (ADP-ribose) polymer, 10-50 unit chain length...
    ... by N.C. Price (1996) • ... on protein chemistry and the ... proteins. Data on the following ... size determination, amino acid analysis ...
    Biology Products: